Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Akadeum Life Sciences said on Wednesday that it is collaborating with Agilent Technologies to develop a new method of isolating target molecules for analytical workflows. Akadeum is currently developing a method that involves microbubbles to

Waters posted revenues of $577.3 million in Q3 compared to $578.0 million in Q3 2018 and falling short of the average Wall Street estimate of $588.9 million. Waters said that foreign currency translation decreased sales growth by around 1 pe

The Stratum Foot Plating System is the next generation of anatomic locking plates designed to optimize ease of use and reduce operating time. The system contains multiple plate and screw options and features tine technology for hand-free app

A new study from the University of South Australia researchers found the number of people that die from bowel or colorectal cancer (CRC) would be much higher without pre-diagnostic colonoscopies. Now more than 700,000 people die from bowel c

Qiagen and Illumina just made a huge commitment to one another. The two companies announced a 15-year partnership to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient managem

Researchers from the University of Strathclyde have developed a blood test that could help to accelerate the diagnosis of brain cancer. The technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial

DiaSorin Molecular has received CE mark for an assay that detects DNA of varicella-zoster virus (VZV) directly from swab specimens, the firm announced today.

Illumina plans to lay off 58 employees, according to documents filed with the State of California Employment Development Department.

PerkinElmer said after the close of the market on Tuesday that it has entered into an agreement for a new $1 billion unsecured revolving credit facility available through Sept. 17, 2024.

Roche announced today its cobas Babesia blood test for individual blood donation testing has received marketing approval from the US Food and Drug Administration.